US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Post-market: 308.600.2700+0.09%19:56 EDT

Volume:355.16K

Turnover:107.82M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.72%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition

Simply Wall St.

How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review

Simply Wall St.

This Healthcare Stock Could Jump Nearly 40%

Luigi Admits Guilt in Killing of UnitedHealthcare CEO, Could Face Life Imprisonment

Health Care Down on Growth Doubts - Health Care Roundup

Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)

Sector Update: Healthcare

MT Newswires Live

DRI Healthcare Posts Record Q1 Income and Bolsters Balance Sheet With New Funding

Vital Healthcare Property Trust (NZSE:VHP) Stock Faces FFO Shock Despite AFFO Support

Simply Wall St.

Dr. Reddy’s Mirfield API Plant Cleared as FDA Closes Inspection With VAI Rating

Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating

Sector Update: Healthcare

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)

FDA Move to Ease Regulatory Pathway Seen as Catalyst for Photocure’s Bladder Cancer Technology

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX) and Prothena (PRTA)

Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)

CIBC Remains a Hold on NorthWest Healthcare Properties REIT (NWHUF)

Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":355161,"hourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Not Yet Opened","change":-8.87,"latestTime":"08-24 16:00:00 EDT","open":314.79,"high":315.4,"low":293,"amount":107824162.61835,"amplitude":0.070618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003292,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"volumeRatio":0.701444,"impliedVol":0.977,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.701444,"shares":2124486,"dividePrice":1.015,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"eps":0,"divideRate":0.003292,"volume":355161,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659827176","title":"Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659827176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659827176?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:30","pubTimestamp":1786818607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DAR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HCSG","BK4581","LABU","XLV","BK4584","BK4588","LU0029874061.USD","BK4137","DIVL","BK4585","DINT","APIE","AADR","XBI","BLTE","DARE","LU0128526141.USD","ARMH","SAPH","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175749","title":"Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659175749?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:20","pubTimestamp":1786818008,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mediwound (MDWD) and Capricor Therapeutics (CAPR)....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","CAPR","MDWD","LU0128526141.USD","XBI","BK4007","BK4137","BK4581","LABU","LU0029874061.USD","BK4585","BK4139","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659017391","title":"The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2659017391","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659017391?lang=en_us&edition=fundamental","pubTime":"2026-08-15 21:27","pubTimestamp":1786800425,"startTime":"0","endTime":"0","summary":"Earlier this week, Alignment Healthcare was highlighted as a top Medicare Advantage pick thanks to strong revenue growth, improving profitability, and a solid net cash position.\nThis recognition underscores how the company’s balance between financial strength and growth ambitions is increasingly shaping investor perceptions of its business model.\nNext, we’ll examine how this focus on strong revenue growth and improving profitability could influence Alignment Healthcare’s broader investment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/the-bull-case-for-alignment-healthcare-alhc-could-change-fol-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/the-bull-case-for-alignment-healthcare-alhc-could-change-fol-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLVX","LU0256863811.USD","BK4539","IEHS","LU1983260115.SGD","XHS","LABU","LU0320765489.SGD","LU0417517546.SGD","LU0070302665.USD","IYH","BK4588","LU0211331839.USD","LU0266013472.USD","UNHU","ALHC","FXH","LU1093756168.USD","BK4154","HUM","LU1093756325.SGD","XLV","LU0170899867.USD","LU0208291251.USD","BK4533","IHF","LU0390134368.USD","BK4566","LU0238689110.USD","LU0348723411.USD","SG9999014013.SGD","LNGR","SG9999014021.USD","BK4581","SG9999014005.SGD","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659173150","title":"How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2659173150","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659173150?lang=en_us&edition=fundamental","pubTime":"2026-08-15 21:21","pubTimestamp":1786800069,"startTime":"0","endTime":"0","summary":"In early August 2026, Scholar Rock Holding Corporation reported that its second-quarter net loss was US$109.9 million, slightly lower than a year earlier, while its six-month net loss widened to US$215.41 million and loss per share stayed broadly similar.\nAt the same time, the company highlighted that its apitegromab biologics license application for spinal muscular atrophy remains under active FDA review with two independent fill-finish facilities prepared to support potential approval and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/how-investors-are-reacting-to-scholar-rock-srrk-dual-fill-fi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-srrk/scholar-rock-holding/news/how-investors-are-reacting-to-scholar-rock-srrk-dual-fill-fi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","IBRN","BK4585","LABU","ISBC","BK4588","SRRK","THNR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659983127","title":"This Healthcare Stock Could Jump Nearly 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659983127","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659983127?lang=en_us&edition=fundamental","pubTime":"2026-08-15 09:30","pubTimestamp":1786757400,"startTime":"0","endTime":"0","summary":"Medpace has carved out a niche helping smaller biotech companies navigate the complicated regulatory process. By Todd ChankoBy the time any of us stop by our local pharmacy to pick up a medication, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU0128526141.USD","LU0648001328.SGD","LU0648000940.SGD","LU0130518102.USD","LU0980610538.SGD","LU0882574055.USD","LU0477156953.USD","LU1791710582.SGD","LU1261432733.SGD","BK4530","LABU","LU1791710400.SGD","LU2065170008.USD","NVIB","BK4121","MEDP","HEAL","BK4137","LU0130103400.USD","LU2065171311.SGD","LU1201861249.SGD","BK4581","LU0130517989.USD","LU0130102774.USD","XLV","LU1989764664.SGD","LU2065171402.SGD","LU0528227936.USD","HCSG","LU0029874061.USD","FTRE","IQV","LU0198837287.USD","LU1989764748.USD","BK4585","LU0477156797.USD","EKG","LU1201861165.SGD","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151695113","title":"Luigi Admits Guilt in Killing of UnitedHealthcare CEO, Could Face Life Imprisonment","url":"https://stock-news.laohu8.com/highlight/detail?id=1151695113","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151695113?lang=en_us&edition=fundamental","pubTime":"2026-08-15 09:20","pubTimestamp":1786756847,"startTime":"0","endTime":"0","summary":"On August 14, local time, Luigi Mangione formally pleaded guilty to the murder of UnitedHealthcare CEO Brian Thompson. A federal judge has set Mangione's sentencing date for December 18.Mangione...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","LABU","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124864","title":"Health Care Down on Growth Doubts - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124864","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124864?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:19","pubTimestamp":1786742340,"startTime":"0","endTime":"0","summary":"Health-care companies fell amid doubts about the growth outlook for the sector.Pfizer shares were more or less flat after Albert Bourla, chief executive of the Big Pharma company, bought $1 million worth of shares, the latest major insider purchase on the open market, following the company's second-quarter earnings report.Luigi Mangione, who is accused of killing a UnitedHealthcare executive, pled guilty to federal stalking charges ahead of a high-profile state murder trial in New York set to begin next month.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","LABU","BK4581","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659121302","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (ANL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659121302","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659121302?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:40","pubTimestamp":1786740009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on US Physical Therapy (USPH) and Adlai Nortye Ltd. Sponsored ADR (A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-us-physical-therapy-usph-and-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-us-physical-therapy-usph-and-adlai-nortye-ltd-sponsored-adr-anl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALN","LABU","BK4585","ANL","DINT","XLV","LU0012050646.USD","SAPH","BK4581","AADR","XBI","USPH","LU0128526141.USD","LU0106261612.USD","DIVL","BK4185","APIE","LU0029874061.USD","HCSG","ARMH","IE00BZ199S13.USD","CVY","BK4137","BK4588","BK4139","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659585126","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2659585126","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659585126?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:22","pubTimestamp":1786735351,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index decreasing 0.4% and the State Street Health Care Select Sector SPDR ETF  shedding 0.5%.The iShares Biotechnology ETF  lost 0.5%.In corporate news, Zentalis Pharmaceuticals  shares fell past 14% in Friday trading, a day after the company priced an offering of 23 million shares at $3.50 each, targeting about $80.5 million in gross proceeds.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","XLV","ZNTL","BK4588","LU0029874061.USD","BK4585","LABU","IBB","LU0128526141.USD","XBI","BK4137","HCSG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659125731","title":"DRI Healthcare Posts Record Q1 Income and Bolsters Balance Sheet With New Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2659125731","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659125731?lang=en_us&edition=fundamental","pubTime":"2026-08-15 02:38","pubTimestamp":1786732696,"startTime":"0","endTime":"0","summary":"DRI Healthcare ( ($TSE:DHT.UN) ) has provided an announcement. DRI Healthcare Trust reported record first-quarter total income of $50.6 million for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dri-healthcare-posts-record-q1-income-and-bolsters-balance-sheet-with-new-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dri-healthcare-posts-record-q1-income-and-bolsters-balance-sheet-with-new-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","BK4581","BK4588","LU0029874061.USD","XLV","HCSG","BK4137","LU0154245756.USD","LU0154245673.USD","DRI","LU0128526141.USD","BK4585","LABU","BK4504","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659125043","title":"Vital Healthcare Property Trust (NZSE:VHP) Stock Faces FFO Shock Despite AFFO Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2659125043","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659125043?lang=en_us&edition=fundamental","pubTime":"2026-08-15 02:32","pubTimestamp":1786732359,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property Trust slipped about 3% over the past week into these results and trades around NZ$1.84, only slightly below one recent fair value estimate. That muted move sits awkwardly beside a headline year shaped by internalization of management and adjusted funds from operations that support a distribution of A$0.0975 per unit.\nThe real story today is the internalization. It removes external fees, tightens alignment with unitholders and feeds directly into management expense...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/real-estate/nzx-vhp/vital-healthcare-property-trust-shares/news/vital-healthcare-property-trust-nzsevhp-stock-faces-ffo-shoc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/real-estate/nzx-vhp/vital-healthcare-property-trust-shares/news/vital-healthcare-property-trust-nzsevhp-stock-faces-ffo-shoc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VHP.NZ","GLS.SI","JJJ.SI","SRU.SI","BK8073","XBI","XLV","CFA.SI","BK8059","CLR.SI","BK4588","SRT.SI","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659312550","title":"Dr. Reddy’s Mirfield API Plant Cleared as FDA Closes Inspection With VAI Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2659312550","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659312550?lang=en_us&edition=fundamental","pubTime":"2026-08-15 02:03","pubTimestamp":1786730607,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Dr. Reddy’s Laboratories Ltd. ( ($IN:DRREDDY) ). Dr. Reddy’s Laboratories has announced that the United States ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dr-reddys-mirfield-api-plant-cleared-as-fda-closes-inspection-with-vai-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dr-reddys-mirfield-api-plant-cleared-as-fda-closes-inspection-with-vai-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659125811","title":"Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2659125811","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659125811?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:15","pubTimestamp":1786727741,"startTime":"0","endTime":"0","summary":"Analyst Oliver McCammon of LifeSci Capital maintained a Buy rating on Celcuity, retaining the price target of $165.00. Oliver McCammon has given hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/unchanged-165-target-as-gedatolisibs-strong-clinical-profile-and-fda-approval-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/unchanged-165-target-as-gedatolisibs-strong-clinical-profile-and-fda-approval-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123104","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123104","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123104?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:05","pubTimestamp":1786727103,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower Friday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF  shedding 0.6%.The iShares Biotechnology ETF  declined 0.8%.In corporate news, Luigi Mangione is expected to plead guilty to federal charges related to the killing of former UnitedHealth  executive Brian Thompson, according to his lawyer, multiple media outlets reported Friday. Mangione faces two counts of stalking in connection with Thompson's death in December 2024, Bloomberg reported. UnitedHealth shares were up 0.5%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BN29S564.USD","LU1670628061.USD","LU0052756011.USD","LU2089984988.USD","LU0316494557.USD","SG9999013999.USD","LU2361045086.USD","LU0211326839.USD","LU1323610961.USD","LU1074936037.SGD","LABU","LU0708995401.HKD","LU0203345920.USD","IHF","SG9999002232.USD","IE0004445015.USD","IE00B7KXQ091.USD","LU0162691827.USD","LU0672654240.SGD","LU0820561909.HKD","LU1732800096.USD","LU0310799852.SGD","IXJ","LU1854103824.USD","SG9999014898.SGD","LU1035773651.USD","LU1914381329.SGD","IE00B894F039.SGD","LU1496350502.SGD","SG9999014906.USD","IE000M9KFDE8.USD","LU0882574055.USD","LU2468319806.SGD","LU0353189763.USD","LU1983299246.USD","IE00B1XK9C88.USD","LU0528227936.USD","LU2264538146.SGD","IE00B4R5TH58.HKD","LU0689472784.USD","BK4585","LU0342679015.USD","SG9999001176.SGD","IE0005OL40V9.USD","LU0553294199.USD","LU1814569148.SGD","SGXZ81514606.USD","TRUH","LU1670627923.USD","IE0002270589.USD","LU1791710582.SGD","LU1988902786.USD","LU2324357040.USD","UNHG","IE00B19Z8W00.USD","LU1064131342.USD","LU0912757837.SGD","VHT","IE00BSNM7G36.USD","IE00BWXC8680.SGD","LU0058720904.USD","LU1267930227.SGD","LU0965509101.SGD","LU2244417387.USD","IE00B775H168.HKD","LU1291159041.SGD","IE00B19Z9Z06.USD","LU0149725797.USD","LU0820561818.USD","LU0354030511.USD","LU0238689110.USD","LU2111349929.HKD","BK4581","XBI","LU1267930730.SGD","LU1674673691.USD","LU2462591277.SGD","LU0320765059.SGD","LU0053666078.USD","LU1934455863.HKD","LU2362541273.HKD","BK4588","IE00BFTCPJ56.SGD","LU2347655156.SGD","LU0976567544.SGD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU0211326755.USD","LU2362540622.SGD","LU0795875169.SGD","SG9999017495.SGD","LU0072461881.USD","LU2023251221.USD","LU0203347892.USD","LU0354030438.USD","LU0949170772.SGD","LU0661504455.SGD","LU0496365809.HKD","LU1057294990.SGD","LU1061106388.HKD","LU1267930490.SGD","LU2028103732.USD","LU2133065610.SGD","LU2242649171.HKD","SGXZ57979304.SGD","JDOC","LU0029864427.USD","LU0353189680.USD","LU2491050154.USD","IE00BFSS8Q28.SGD","XLV","LU2125154935.USD","LU0158827948.USD","IE00BJJMRX11.SGD","LU0107464264.USD","LU0310800379.SGD","IBB","LU0557290698.USD","LU0820562030.AUD","RXL","LU0077335932.USD","IE00B19Z9P08.USD","LU2087625088.SGD","LU2999663052.SGD","LU2552382215.SGD","LU1037948897.HKD","IE00B4JS1V06.HKD","IE00B2B36J28.USD","LU0965509283.SGD","LU1066051225.USD","MHIP","LU1854104046.USD","IE00B19Z3B42.SGD","LU0122379950.USD","LU1261432733.SGD","SG9999018865.SGD","IE00BJJMRY28.SGD","BK4534","LU0289739699.SGD","LU1934455194.USD","LU0345770308.USD","LU1778281490.HKD","LU1066051498.USD","LU2357305700.SGD","LU1791710400.SGD","LU0787776722.HKD","SG9999002224.SGD","SGXZ99366536.SGD","IE0004445239.USD","IE0002141913.USD","IE00B19Z9505.USD","LU2279689827.SGD","LU1037948541.HKD","LU2461242641.AUD","SG9999014914.USD","LU1732799900.SGD","LU0109391861.USD","LU0943347566.SGD","SGXZ31699556.SGD","LU0211328371.USD","SG9999014880.SGD","LU2552382132.HKD","LU0256863811.USD","SG9999001176.USD","LU0128525929.USD","LU0211327993.USD","BK4532","LU1989771016.USD","LU2360032135.SGD","LU1551013425.SGD","FHLC","LU0011850046.USD","LU2491049909.HKD","HRTS","IYH","LU0965509010.AUD","IE00BFXG1179.USD","LU2211815571.USD","LU0310800965.SGD","LU1066053197.SGD","LU1506573853.SGD","LU2552382058.USD","SG9999018857.SGD","LU0143551892.USD","LU2125154778.USD","LU1551013342.USD","LU0432979614.USD","LU1066051811.HKD","TMED","IE00B19Z8X17.USD","LU1069347547.HKD","LU1548497426.USD","UNHW","LU1119994496.HKD","LU0198837287.USD","SGXZ51526630.SGD","LU0158827781.USD","IE00B19Z3581.USD","LU2491050071.SGD","IE00BFSS7M15.SGD","LU0048584097.USD","LU1084165304.USD","LU2362541513.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU1934455277.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU0456855351.SGD","IE00BKVL7J92.USD","IE0009355771.USD","LU0251132253.USD","IE00BJJMRZ35.SGD","LU0266013472.USD","LU1003077747.HKD","BK4533","BK4566","LU2271345857.HKD","LU0094547139.USD","LU0861579265.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","LU0545039389.USD","LU0417517546.SGD","LU0708994859.HKD","LU0097036916.USD","LU0128525689.USD","LU0079474960.USD","SUNH0main","LU1720051017.SGD","LU2954938101.SGD","IE00BKPKM429.USD","LU1153585028.USD","LU2112291526.USD","LU0114720955.EUR","LU0795875086.SGD","LU0965508806.USD","LU0187121727.USD","LU1718418525.SGD","UNHU","UNH","IE00BZ9MQY76.HKD","GDOC","LU0234572021.USD","LU1674673428.USD","LU2089283258.USD","BK4154","LU0823416689.USD","LU2089284900.SGD","LU0345770993.USD","LU0738911758.USD","LU2236285917.USD","LU2361044865.SGD","LU1720051108.HKD","LU0683600562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123102","title":"Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123102?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:00","pubTimestamp":1786726822,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Su...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-ionis-pharmaceuticals-ions-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-ionis-pharmaceuticals-ions-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4007","DFTX","BK4585","BK4139","LU0128526141.USD","STRO","BK4588","BK4581","IONS","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123823","title":"FDA Move to Ease Regulatory Pathway Seen as Catalyst for Photocure’s Bladder Cancer Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123823","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123823?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:21","pubTimestamp":1786724515,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Photocure ASA ( ($PHCUF) ). Photocure ASA reported that the U.S. Food and Drug Administration has issued a prop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fda-move-to-ease-regulatory-pathway-seen-as-catalyst-for-photocures-bladder-cancer-technology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fda-move-to-ease-regulatory-pathway-seen-as-catalyst-for-photocures-bladder-cancer-technology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123357","title":"Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX) and Prothena (PRTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123357","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123357?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:10","pubTimestamp":1786723806,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gain Therapeutics (GANX) and Prothena (PRTA). Gain...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gain-therapeutics-ganx-and-prothena-prta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gain-therapeutics-ganx-and-prothena-prta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4585","GANX","BK4137","LU0128526141.USD","LU0029874061.USD","XLV","BK4139","XBI","BK4588","LABU","PRTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659140050","title":"Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Alto Neuroscience, Inc. (ANRO) and Irhythm Technologies (IRTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659140050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659140050?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:20","pubTimestamp":1786720810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on 4D Molecular Therapeutics (FDMT), Alto Neuroscience,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-4d-molecular-therapeutics-fdmt-alto-neuroscience-inc-anro-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-4d-molecular-therapeutics-fdmt-alto-neuroscience-inc-anro-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRTC","LU0029874061.USD","XLV","BK4581","BK4563","LU0128526141.USD","BK4585","LABU","HCSG","BK4137","BK4588","BK4082","XBI","BK4007","FDMT","ANRO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659099140","title":"CIBC Remains a Hold on NorthWest Healthcare Properties REIT (NWHUF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659099140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659099140?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:17","pubTimestamp":1786720664,"startTime":"0","endTime":"0","summary":"CIBC analyst Dean Wilkinson maintained a Hold rating on NorthWest Healthcare Properties REIT today and set a price target of C$6.25. Wilkinson cove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cibc-remains-a-hold-on-northwest-healthcare-properties-reit-nwhuf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cibc-remains-a-hold-on-northwest-healthcare-properties-reit-nwhuf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","RJMG","BK4203","XLV","DFRA","NWHUF","HCSG","YLDW","MDIV","LU0128526141.USD","IQRA","REIT","LABU","REIX","RNTY","XBI","PSCF","BK4585","BK4225","BK4137","BK4581","IVRA","BPRE","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659442411","title":"Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2659442411","media":"Benzinga Earnings","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659442411?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:25","pubTimestamp":1786713933,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics highlights Deramiocel&#39;s FDA review, commercial readiness, and cash position of $approximately $237.9 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/08/61208545/capricor-therapeutics-remains-optimistic-about-deramiocel-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","CAPR","LABU","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":13,"totalSize":403,"code":"91000000","status":"200"}]}}